Search results for "Reference drug"

showing 6 items of 6 documents

ChemInform Abstract: Synthesis and Antifungal Activity of New N-Isoxazolyl-2-iodobenzamides.

2010

N-Isoxazolyl-2-iodobenzamides 3 and 9, with a benodanil-like structure, were synthesized by refluxing in acetic acid the corresponding benzotriazinones 2 and 8 with potassium iodide for 1 h with the aim to ascertain if they were active as fungicides against Phytophthora citricola Saw., Botrytis cinerea Pers., Rhizoctonia sp. and Alternaria sp. Among the tested iodo derivatives, compounds 3b and 9a possess interesting activities against the aforesaid fungal strains in several cases similar to that of benodanil I taken as reference drug.

AntifungalPhytophthora citricolabiologymedicine.drug_classfungifood and beverageschemistry.chemical_elementGeneral MedicineIodineReference drugbiology.organism_classificationFungicideAcetic acidchemistry.chemical_compoundchemistrymedicineOrganic chemistryRhizoctonia sp.Botrytis cinereaChemInform
researchProduct

Getting new bronchodilator compounds from molecular topology.

2003

Abstract Molecular topology has been used to select new lead bronchodilator compounds. The main advantage of this method, as compared to others frequently used, is that it does not require a previous explicit knowledge of the mechanism of action (MOA) of the compounds analyzed. A large database (12,000 chemicals) has been examined in this study to find less than 5% compounds with bronchodilator activity. After removing those compounds already described as bronchodilators, we present here the results for 20 among these compounds, some of them showing other pharmacological activities. Some of the compounds selected in this study showed higher relaxation and higher potency than theophylline, w…

IndolesChemistrymedicine.drug_classMolecular ConformationPharmaceutical SciencePharmacologyModels TheoreticalReference drugBronchodilator AgentsStructure-Activity RelationshipPharmaceutical technologyEllagic AcidTheophyllineBronchodilatormedicinePotencyTheophyllineMolecular topologymedicine.drugEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
researchProduct

New Analgesics Designed by Molecular Topology

1996

Molecular topology has been applied to the design of new analgesic drugs, utilizing linear discriminant analysis and connectivity functions using different topological descriptors. Of a total of 26 compounds selected, 17 showed analgesic activity. The following stood out particularly, showing analgesic values greater than 75% regarding ASA (acetylsalicylic acid), the reference drug: 2-(1-propenyl)phenol, 2′4′ dimethylacetophenone, p-chlorobenzohydrazide, 1-(p-chlorophenyl) propanol and 4-benzoyl-3-methyl-1-phenyl-2-pyrazolin-5-one. The usefulness of the design method has been demonstrated in the search of new chemical structures having analgesic effects, some of which could become “lead dru…

PharmacologyPropanolchemistry.chemical_compoundchemistryStereochemistryAnalgesicMolecular topologyReference drugLinear discriminant analysisCombinatorial chemistryQuantitative Structure-Activity Relationships
researchProduct

New Hypolipaemic Agents Designed by Molecular Topology: Pharmacological Studies of 2,6-Di-tert-butyl-4-methylpyridine and 2,6-Di-tert-butylpyridine

1999

New compounds showing hypolipaemic activity have been designed using a computer-aided method based on molecular topology and QSAR analysis. Linear discriminant analysis and connectivity functions were used to design three potentially suitable drugs which were tested for hypolipaemic properties by the Triton WR-1339 test in rats. The pharmacological tests carried out on the newly designed compounds demonstrated the existence of notable activity in phase I for two of them. namely 2,6-Di-tert-butyl-4-methylpyridine (C.A.S. 38222-83-2) and 2,6-Di-tert-butylpyridine (C.A.S. 585-48-8), with respect to the level of total cholesterol. Both substances decrease the lipaemia to lower levels than clofi…

PharmacologyTert butylQuantitative structure–activity relationshipClofibrateChemistryStereochemistry26-Di-tert-butylpyridineReference drugchemistry.chemical_compoundTotal cholesterol4-MethylpyridinemedicineMolecular topologymedicine.drugQuantitative Structure-Activity Relationships
researchProduct

Search for New Antihistaminic Compounds by Molecular Connectivity

1999

In this paper it is demonstrated that by adequate selection of topological descriptors we can make possible the prediction of different pharmacological properties, such as plasmatic concentration or sedative effect, within a group of antihistaminic drugs. Moreover, also demonstrated is the usefulness of molecular connectivity in the search of new active compounds. Examples of such compounds are 4-(l-buthylpenthyl)pyridine, N-(3-bromopropyl)-phtalimide and N-(3-chlorpropyl)-piperidin hydrochloride. All of them show antihistaminic activity values more than 30% higher than that of terfenadine, which is used as the reference drug.

Pharmacologychemistry.chemical_compoundSedative effectchemistryHydrochloridemedicineAntihistaminic drugsOrganic chemistryTerfenadineReference drugCombinatorial chemistrymedicine.drugQuantitive Structure-Activity Relationships
researchProduct

Vanilloid Derivatives as Tyrosinase Inhibitors Driven by Virtual Screening-Based QSAR Models

2010

A number of vanilloids have been tested as tyrosinase inhibitors using Ligand-Based Virtual Screening (LBVS) driven by QSAR (Quantitative Structure-Activity Relationship) models as the multi-agent classification system. A total of 81 models were used to screen this family. Then, a preliminary cluster analysis of the selected chemicals was carried out based on their bioactivity to detect possible similar substructural features among these compounds and the active database used in the QSAR model construction. The compounds identified were tested in vitro to corroborate the results obtained in silico. Among them, two chemicals, isovanillin (K(M) (app) = 1.08 mM) near to kojic acid (reference d…

Quantitative structure–activity relationshipStereochemistryTyrosinaseIn silicoQuantitative Structure-Activity RelationshipPharmaceutical ScienceIsovanillinModels BiologicalSkin DiseasesVanilloidsAnalytical Chemistrychemistry.chemical_compoundCluster AnalysisHumansEnvironmental ChemistryComputer SimulationEnzyme InhibitorsSpectroscopyVirtual screeningMonophenol MonooxygenaseReference drugCombinatorial chemistrychemistryBenzaldehydesDrug DesignKojic acidAlgorithmsDrug Testing and Analysis
researchProduct